|
Originally published In Press as doi:10.1074/jbc.M208191200 on October 2, 2002
J. Biol. Chem., Vol. 277, Issue 49, 47917-47927, December 6, 2002
The Ccz1-Mon1 Protein Complex Is Required for
the Late Step of Multiple Vacuole Delivery Pathways*
Chao-Wen
Wang ,
Per E.
Stromhaug ,
Jun
Shima §, and
Daniel
J.
Klionsky¶
From the Department of Molecular, Cellular, and
Developmental Biology and the Department of Biological Chemistry and
the Life Sciences Institute, University of Michigan, Ann Arbor,
Michigan 48109
Received for publication, August 9, 2002, and in revised form, September 30, 2002
 |
ABSTRACT |
Mon1 and Ccz1 were identified from a gene
deletion library as mutants defective in the vacuolar import of
aminopeptidase I (Ape1) via the cytoplasm to vacuole targeting (Cvt)
pathway. The mon1 and ccz1 strains also
displayed defects in autophagy and pexophagy, degradative pathways that
share protein machinery and mechanistic features with the biosynthetic
Cvt pathway. Further analyses indicated that Mon1, like Ccz1, was
required in nearly all membrane-trafficking pathways where the vacuole
represented the terminal acceptor compartment. Accordingly, both
deletion strains had kinetic defects in the biosynthetic delivery of
resident vacuolar hydrolases through the CPY, ALP, and MVB pathways.
Biochemical and microscopy studies suggested that Mon1 and Ccz1
functioned after transport vesicle formation but before (or at) the
fusion step with the vacuole. Thus, ccz1 and
mon1 are the first mutants identified in screens for the
Cvt and Apg pathways that accumulate precursor Ape1 within
completed cytosolic vesicles. Subcellular fractionation and
co-immunoprecipitation experiments confirm that Mon1 and Ccz1
physically interact as a stable protein complex termed the Ccz1-Mon1
complex. Microscopy of Ccz1 and Mon1 tagged with a fluorescent marker
indicated that the Ccz1-Mon1 complex peripherally associated with a
perivacuolar compartment and may attach to the vacuole membrane
in agreement with their proposed function in fusion.
 |
INTRODUCTION |
Compartmentalization allows eukaryotic cells to regulate
intracellular functions by separating competing reactions and
localizing enzymes and substrates at specific locations within the
cell. Efficient compartmentalization necessitates dynamic protein
trafficking processes by which cells are able to establish and maintain
the identity and function of each organelle. The vacuole (lysosome) of
the yeast Saccharomyces cerevisiae plays a central role in the turnover of cytoplasmic organelles, degradation of
intracellular/extracellular components, and maintenance of cellular
physiology (1). To carry out these functions, the vacuole maintains a
variety of degradative enzymes. Both resident hydrolases and their
substrates arrive at this destination through a variety of sorting
pathways. The main routes by which vacuolar hydrolases are delivered to this organelle are the carboxypeptidase Y
(CPY),1 alkaline phosphatase
(ALP), and multivesicular body (MVB) pathways, which involve transit
through a portion of the secretory pathway, and the cytoplasm to
vacuole targeting (Cvt) pathway by which the cargo molecules are
packaged as cytosolic membrane-bound intermediates (2, 3). Resident
proteins are also transmitted by inheritance from mother cell vacuoles
to daughter cells during cell division (4). Substrates enter the
vacuole through endocytosis, autophagy and the vacuole import and
degradation pathway (reviewed in Ref. 5). One common feature in all of
these processes is membrane fusion. The membrane fusion mechanism acts
to ensure specificity for the directed movement of proteins while also
maintaining the distinct composition of each organelle within the
highly compartmentalized eukaryotic cell.
The cytoplasm to vacuole targeting pathway that is used to deliver the
soluble hydrolase aminopeptidase I (Ape1) to the vacuole has been under
investigation (for reviews see Refs. 2, 5, and 6). Under vegetative
conditions, precursor Ape1 (prApe1) is assembled into a large Cvt
complex composed in part of multiple prApe1 dodecamers in the cytosol
that becomes enwrapped within a double-membrane Cvt vesicle (7). Upon
completion, the cytosolic Cvt vesicle targets to the vacuole. The outer
membrane of the Cvt vesicle fuses with the vacuole membrane and the
intact inner vesicle (Cvt body) passes into the vacuole lumen (8). The
Cvt body is ultimately broken down by resident vacuolar hydrolases, resulting in the release and maturation of prApe1. Precursor Ape1 is
transported to the vacuole by another pathway, termed autophagy (Apg),
under starvation conditions (2, 9). In the Apg pathway, portions of
cytoplasm are sequestered within relatively larger double membrane
vesicles (autophagosomes) that are also targeted to the vacuole (7).
Although Apg is a degradative process, mutants defective in autophagy,
apg/aut, overlap with cvt mutants (10). Morphological and biochemical analyses further indicate that the
Cvt and Apg pathways use analogous mechanisms (2, 5, 9).
To gain additional insight into the Cvt/Apg pathways, we screened a
gene deletion library for mutants that are defective in prApe1
maturation. We found two mutants that are required for Cvt/Apg import
that had not been previously implicated in these pathways. The product
of one of these genes, Ccz1, has been suggested to be involved in
multiple trafficking pathways to the vacuole (11). Overexpression of
the Rab protein Ypt7 rescues the sensitivity to calcium, caffeine, and
zinc observed with the ccz1 strain. The
Ypt7K127E mutant has been identified as a specific mutation
that suppresses the ccz1 phenotype (12).
Co-immunoprecipitation data further support the physical interaction
between Ccz1 and Ypt7 (12). The mon1 strain is sensitive
to monensin and brefeldin A (13), but is otherwise uncharacterized. In
this study, we show that strains lacking either of these two proteins
have similar phenotypes. Both Mon1 and Ccz1 are required not only for
the Cvt/Apg pathways but also other vacuole biogenesis processes
including the sorting of newly synthesized vacuolar proteins through
the CPY, ALP, and MVB pathways and endocytosis. Biochemical and
morphological evidence further indicate that the Cvt/Apg pathways are
blocked at a stage after the formation of the sequestering vesicles but
prior to their fusion with the vacuole. These studies also suggest that Ccz1 and Mon1 co-localize to a unique membrane and that they physically interact. Finally, we demonstrate the in vivo localization
of these two proteins to a perivacuolar compartment and the vacuole membrane, a site consistent with their proposed role in fusion.
 |
EXPERIMENTAL PROCEDURES |
Strains, Media, and Growth Conditions--
The yeast strains
used in this study are listed in Table I.
Synthetic minimal medium (SMD) contained 0.67% yeast nitrogen base
without amino acids, 2% glucose, and auxotrophic amino acids and
vitamins as needed. Nitrogen starvation medium (SD-N) contained 0.17%
yeast nitrogen base without amino acids and ammonium sulfate and 2%
glucose. YPD medium contained 1% yeast extract, 2% peptone, and 2%
glucose. S. cerevisiae strains were grown at 30 °C. Yeast cells used for this study were grown in the appropriate SMD medium to
mid-log (OD600 of 0.6).
Reagents and Antisera/Antibodies--
Reagents for growth medium
were from Difco Laboratories (Detroit, MI). DNA restriction enzymes, T4
DNA ligase and calf intestinal alkaline phosphatase were obtained from
New England Biolabs, Inc. (Beverly, MA). Tran[35S] label
was obtained from ICN (Costa Mesa, CA). Oxalyticase was from
Enzogenetics (Corvallis, OR). OptiPrepTM was from Accurate
Chemical and Scientific Corp. (Westbury, NY). CompleteTM
EDTA-free protease inhibitor was obtained from Roche Molecular Biochemicals. The pME3 vector containing the Schizosaccharomyces pombe HIS5 auxotrophic marker was a gift from Dr. Neta Dean (State University of New York, Stony Brook, NY). The pFA6a knockout and tagging vectors containing TRP1, HIS3, or
KanMX markers were generous gifts from Dr. Mark Longtine
(Oklahoma State University) (14). The CFP (pDH3) and YFP (pDH5)
plasmids were from the Yeast Resource Center (University of
Washington). FM 4-64 dye was obtained from Molecular Probes
(Eugene, OR). All other reagents were from Sigma-Aldrich. Antisera
against Ape1 (15), Prc1 (16), and Pep4 (16) have been described.
Antisera against Pgk1, Ypt7, and Anp1 were provided by Dr. Jeremy
Thorner (University of California, Berkeley, CA), Dr. William Wickner
(Dartmouth Medical School, Hanover, NH), and Dr. Sean Munro (MRC
Laboratory of Molecular Biology, Cambridge, UK), respectively.
Antibodies against Pho8, Dpm1, and Pep12 were obtained from Molecular
Probes, and the anti-HA antibody was purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). To prepare antiserum against
Mon1, the NH2 terminus of the Mon1 ORF (1-585 bp) was
PCR-amplified and fused to the COOH terminus of the maltose-binding protein. The resulting plasmid was transformed into E. coli
strain BL21. Fusion protein purification and antiserum generation were as described (17).
Screening the Haploid Gene Deletion Library--
A
MAT haploid gene deletion library was obtained from
ResGen/Invitrogen Corporation (Huntsville, AL). The mutants provided from the company were inoculated on YPD plates and incubated at 30 °C for 12-24 h. The cells on YPD plates were collect and
resuspended in 50 µl of MURB (50 mM NaPO4, 25 mM MES, pH 7.0, 1% SDS, 3 M urea, 0.5%
-mercaptoethanol, 1 mM NaN3, and 0.05%
bromphenol blue) and converted into crude cell extracts by glass bead
lysis and boiling. The extracts were subjected to immunoblot analysis using anti-Ape1 antisera.
Disruption, Epitope Tagging, and Gene Cloning--
The
chromosomal MON1 and CCZ1 loci were deleted by a
PCR-based, one-step procedure (18). In brief, the corresponding
auxotrophic marker was amplified from the pME3 or pFA6a knockout
plasmids by PCR using oligonucleotides that contained sequences outside of the marker, flanked by sequences that encode regions at the beginning and end of the corresponding ORFs. PCR products were used to
transform yeast strain SEY6210. Putative knockout strains were checked
by Western blot for the Ape1 phenotype. Similar strategies were applied
for the chromosomal HA and fluorescent protein tagging. To clone the
MON1 and CCZ1 genes, both ORFs and their
upstream/downstream sequences were PCR-amplified using genomic DNA as
template. The resulting PCR products for MON1 include 360 bp
before the sequence encoding the start codon and 405 bp after the stop
codon. The fragments were digested with SacI and
SmaI and inserted into the SacI and
SmaI site of the pRS416/426 vector to generate plasmids pMON1(416/426). The PCR products for the cloning of CCZ1
contain ~300-bp upstream and 700-bp downstream of the CCZ1
ORF. The PCR products were digested with KpnI to generate
pCCZ1(416/426). To construct COOH-terminal HA epitope-tagged Ccz1, the
CCZ1 ORF was PCR-amplified using pCCZ1(416) as a template.
The resulting PCR product was digested and inserted into pRS416HA and
pRS426HA that contains a 3×HA epitope (19). To construct an
NH2-terminal YFP fusion to Mon1, the MON1 ORF
was PCR-amplified using pMON1 (416) as a template. The resulting PCR
products were inserted into pCuYFP (306) to generate pCuYFP-MON1 (306).
The construct was linearized with KpnI and transformed into
strain PSY44 to replace endogenous MON1 with pCuYFP-MON1
(strain PSY45). The plasmids pCvt19-CFP(414) (20), pSte3-GFP(316) (21),
pCuGFP-Aut7 (416) (22), pGFP-Pho8(426) (23), and pSna3-GFP(416) (24)
were described previously. All oligonucleotide sequences and additional
details of the plasmid constructions will be provided upon request.
Immunoblot Analysis, Pulse/Chase Labeling, and
Immunoprecipitation--
Immunoblot analysis was carried out
essentially as described previously (25). For kinetic analysis of Prc1,
yeast cells were grown to an OD600 of 1.0 and converted
into spheroplasts. The spheroplasts from 20 OD600 units of
cells were resuspended in 300 µl of SMD medium containing 1.3 M sorbitol, and labeled with 20 µCi of
Tran[35S] label for 5 min, followed by a chase reaction
in SMD containing 1.3 M sorbitol, 0.2% yeast extract, 4 mM methionine, and 2 mM cysteine at a final
density of 2.0 OD600/ml. Samples were removed at the
indicated time points and 1 mM NaN3 was added
to stop the reaction. The samples were subjected to a 5,000 × g centrifugation for 3 min. The resulting supernatant and
pellet fractions were separately precipitated with 10% trichloroacetic
acid. Trichloroacetic acid precipitates were resuspended in MURB buffer
and subjected to immunoprecipitation as described previously (25). For
kinetic analyses of Ape1, Pep4, and Ste3, yeast cells were grown to an OD600 of 1.0 in SMD medium. Cells (20 OD600
units) were resuspended in 300 µl of SMD medium and labeled with 20 µCi of Tran[35S] label for 5-10 min, followed by a
chase reaction as above at a final density of 20 OD600/ml.
Samples were removed at the indicated time points and precipitated with
10% trichloroacetic acid. Crude extracts were prepared by glass bead
lysis and subjected to immunoprecipitation as described previously
(25).
Analyses of the Cvt Pathway and Autophagy--
Cell viability
and starvation curves and peroxisome degradation rates were determined
as described previously (17). The membrane flotation assay was
performed essentially by the method described previously (26) with
minor modifications. Spheroplasts derived from the mon1
strain were resuspended in PS200 lysis buffer (20 mM PIPES,
pH 6.8, 200 mM sorbitol) containing 5 mM MgCl2 at a spheroplast density of 20 OD600/ml.
The lysate was centrifuged at 13,000 × g for 5 min at
4 °C. The pellet fractions from 10 OD600 units of cells
were resuspended in 100 µl of 15% Ficoll-400 (w/v) in lysis buffer
with or without the addition of 0.2% Triton X-100. The resuspended
pellet fractions were overlaid with 1 ml of 13% Ficoll-400 in lysis
buffer and then overlaid with 200 µl of 2% Ficoll-400 in lysis
buffer. The resulting step gradient was subjected to centrifugation at
13,000 × g for 10 min at 4 °C. The top 500 µl was
designated as the float fraction (F), the remaining solution was
considered as the nonfloat fraction (NF), and the gradient pellet was
designated as the pellet fraction (P). The three fractions were
trichloroacetic acid-precipitated, washed twice with acetone, and
analyzed by immunoblot. The protease protection assay was performed as
described previously (17). In brief, log-phase cultures were subjected
to osmotic lysis in PS200 containing 5 mM
MgCl2. The lysates were centrifuged at 13,000 × g for
10 min, and the pellet fractions (P13) were resuspended in lysis buffer
in the presence or absence of 50 µg/ml proteinase K and/or 0.2%
Triton X-100. Reactions were carried out on ice for 30 min followed by
trichloroacetic acid precipitation and immunoblot analysis.
Subcellular Fractionation and OptiPrepTM Density
Gradient Analysis--
Mon1-HA cells expressing pCcz1-HA(416) were
grown to mid-log phase (OD600 = 0.6) in SMD medium. The
cells were converted into spheroplasts and resuspended in PS200 lysis
buffer containing 5 mM MgCl2 and the
CompleteTM EDTA-free protease inhibitor mixture at a
density of 20 OD600/ml. After a preclearing spin (500 × g, for 5 min, at 4 °C), the total lysate was subjected
to low-speed centrifugation (13,000 × g for 10 min),
resulting in the supernatant (S13) and pellet (P13) fractions. The S13
fraction was subjected to high speed centrifugation (100,000 × g for 30 min at 4 °C) to generate the supernatant (S100)
and pellet (P100) fractions. The resulting fractions were subjected to
immunoblot analysis. To examine membrane binding of Ccz1-HA and Mon1-HA
the membrane fractions from lysed spheroplasts were treated with 1 M KCl, 0.1 M Na2CO3 (pH
10.5), 3 M urea, or 1% Triton X-100 as described
previously (17). OptiPrepTM density gradient analysis was performed
using a modification of a previously described procedure (17). In
brief, a Mon1-HA strain expressing Ccz1-HA was grown to mid-log phase
(OD600 = 0.6) and converted into spheroplasts. The
spheroplasts were subjected to osmotic lysis in PS200 containing 1 mM EDTA, 1 mM MgCl2, and a protease inhibitor mixture (CompleteTM EDTA-free protease inhibitor
tablets, 1 µg/ml leupeptin and 1 µg/ml pepstatin A). The lysate was
subjected to very low speed centrifugation (800 × g
for 5 min) to remove the remaining intact spheroplasts. After this
preclearing step, the crude lysate from 35 OD600 units of
cells was centrifuged at 100,000 × g for 20 min at
4 °C. The resulting total membrane fraction was resuspended in 200 µl of lysis buffer and then applied on top of a density gradient (12 ml, linear) consisting of 10-55% OptiPrepTM in PS200 lysis buffer
containing 1 mM EDTA, 1 mM MgCl2, 1 mM dithiothreitol, and a protease inhibitor mixture. The
gradients were subjected to centrifugation at 100,000 × g for 12 h at 4 °C in a Sorvall Th-641 rotor.
Samples were collected from the top of the gradients into 14 fractions.
The fractions were trichloroacetic acid-precipitated and washed twice
with acetone followed by immunoblot analyses.
Native Immunoprecipitation--
The protocol for
co-immunoprecipitation with Ccz1-HA was modified from a previously
described procedure (12). In brief, 10 OD600 units of
log-phase cells were lysed with glass beads in lysis buffer (50 mM HEPES, pH 7.4, 150 mM KCl, 1 mM
EDTA, 0.5% Triton X-100) with the addition of protease inhibitor
mixture and 1 mM phenylmethylsulfonyl fluoride. After a
10-min solubilization on ice, total cell lysates were centrifuged at
13,000 × g for 15 min at 4 °C. To the resulting
supernatant, 10 µl of anti-HA antiserum was added followed by
incubation with protein A-Sepharose at 4 °C overnight. Sepharose
beads were washed with lysis buffer a total of eight times. Bound
proteins were eluted in MURB followed by SDS-PAGE and Western blot analysis.
Microscopy--
All strains used for microscopy were grown in
SMD medium to mid-log phase. In vivo FM 4-64 staining
was performed as described previously (27). Microscopy analysis was
performed using a Nikon E-800 fluorescent microscope (Mager Scientific
Inc., Dexter, MI). Images were captured by an ORCA II CCD camera
(Hamamatsu Corp., Bridgewater, NJ) using Openlab 3 software
(Improvision, Inc., Lexington, MA).
 |
RESULTS |
Mon1 and Ccz1 Are Required for the Cvt, Autophagy, and Pexophagy
Pathways--
Although various cvt, apg, and
aut mutants defective in the Cvt and Apg pathways have been
isolated and analyzed (reviewed in Refs. 5 and 28), many questions
concerning these pathways remain to be answered. We are interested in
the molecular mechanism governing the dynamic aspects of the Cvt and
Apg pathways. We reasoned that the identification of additional mutants
would provide further insight into the protein machinery of these
processes. Accordingly, we screened a haploid gene deletion library
based on the accumulation of prApe1, a cargo protein that is delivered to the vacuole through the Cvt/Apg pathways. Among the new mutants identified, mon1 and ccz1 showed a complete
block in prApe1 maturation. Although mon1 has not been
previously reported as having a role in the Cvt pathway,
complementation analyses indicate that CCZ1 is allelic with
CVT16, a previously uncharacterized CVT gene
(10). The ccz1 mutant was originally identified due to
its sensitivity to caffeine, calcium, and
zinc (29). It has also been shown that the strain displays a
severe vacuole protein-sorting defect. Immunofluorescent data suggest
that Ccz1 localizes to the endosomal compartment, and it has been
suggested to act in concert with the Rab protein Ypt7 (11, 12). There
has not been a published report describing Mon1 function. The
MON1 gene, YGL124c, encodes a 644-amino acid
protein with a predicted molecular mass of 73.5 kDa. A data base search
indicates that Mon1 does not have homology with other proteins of
S. cerevisiae. However, possible homologues having 24-37%
identity with Mon1 exist in S. pombe,
Caenorhabditis elegans, and Drosophila
melanogaster. Ccz1 has no significant homologues.
When wild type cells are grown under nutrient-rich conditions, the
majority of Ape1 is present as the 50-kDa mature form (Fig. 1A), although a small fraction
is present as the 61-kDa precursor. In contrast, both the
mon1 and ccz1 strains accumulated only the
precursor form of Ape1. The defect in prApe1 processing in these
mutants was rescued by expressing either single or multicopy versions
of the corresponding genes on plasmids, confirming the essential roles
of Mon1 and Ccz1 for the Cvt pathway (Fig. 1A). Precursor
Ape1 is delivered to the vacuole through autophagy under starvation
conditions. We utilized a starvation-sensitivity analysis to determine
whether the mon1 and ccz1 strains were able
to carry out autophagy. Wild type cells, or mutants specific to the Cvt
pathway, are starvation-resistant while mutants defective for autophagy
lose viability in the absence of nitrogen (17). As shown in Fig.
1B, the wild type strain was resistant to starvation over
the time course examined. In contrast, mon1 and
ccz1 strains, similar to the apg1 mutant,
displayed a rapid loss of viability in SD-N medium. Viability in the
mon1 strain was restored when these cells expressed Mon1
from a CEN-based plasmid.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 1.
The ccz1
and mon1 strains are defective in
the Cvt, autophagy, and pexophagy pathways. A, cloning
and characterization of CCZ1 and MON1. Wild type
(WT, SEY6210), ccz1 (CWY3), and mon1 (JSY1)
strains and the knockout strains expressing the respective single copy
(CEN) or multicopy (2µ) plasmids were grown in SMD medium
and analyzed by immunoblot against Ape1. B,
mon1 and ccz1 strain are sensitive to
nitrogen-starvation conditions. The wild type, apg1 , and
mon1 strains and the mon1 strain harboring
pMON1(416) or the wild type and ccz1 strains were grown
to mid-log phase in SMD medium and shifted to SD-N medium. At the
indicated time, aliquots were removed and spread onto YPD plates in
triplicate. The number of viable colonies was counted after 2 days
incubation at 30 °C. C, mon1 and
ccz1 mutants do not bypass the prApe1 accumulation defect
when autophagy is induced. The vac8 (D3Y102),
apg1 (NNY20), ccz1 , and mon1
strains were grown to mid-log phase in SMD and shifted to SD-N medium.
At the indicated time, aliquots were removed and subjected to
immunoblot against Ape1. D, mon1 and
ccz1 strains are defective for pexophagy. The wild type,
ccz1 and mon1 strains in the BY4742
background were grown in YPD to mid-log phase, transferred to oleic
acid medium to induce peroxisome production and shifted to SD-N.
Aliquots were removed at the indicated times and analyzed by Western
blot with antiserum to Fox3.
|
|
Starvation-sensitivity indicates that autophagy is not fully functional
in the mon1 and ccz1 strains. Recently,
however, we have demonstrated that some mutants that are autophagy
defective by this criterion are still able to induce the formation of
autophagosomes under starvation conditions. For example, the
aut7 strain is starvation-sensitive but is able to induce
the formation of small, abnormal autophagosomes in SD-N (30). In
addition, some components of the Cvt and Apg pathways are only
essential for one of these two pathways. For example, Vac8 and Cvt9 are
only required for the Cvt pathway whereas Apg17 appears to function
only in autophagy (26, 31, 32). Accordingly, these types of mutants are
able to mature prApe1 under starvation conditions. We extended our analysis of autophagy by examining the role of Ccz1 and Mon1 in prApe1
import under nutrient-deprivation conditions. Strains were grown in SMD
to mid-log phase, shifted to medium lacking nitrogen (SD-N), and the
time course of prApe1 processing was examined by Western blot (Fig.
1C). As expected, the vac8 strain showed a
reversal of the prApe1 accumulation defect after cells were shifted to
SD-N. In contrast, the apg1 mutant that is defective for
both the Cvt and Apg pathways was unable to process prApe1 due to its
defect in autophagosome formation. Similar to the apg1 strain, the mon1 and ccz1 strains retained
the precursor form of Ape1 in starvation conditions, suggesting that
these two proteins are absolutely required for autophagy. The block in
prApe1 maturation in SD-N was consistent with the starvation
sensitivity phenotype. Thus, we conclude that Mon1 and Ccz1 are
required for both the Cvt and autophagy pathways.
We have reported previously that the peroxisome degradation pathway,
pexophagy, uses similar molecular components as the Cvt and autophagy
pathways (33). To investigate if Mon1 and Ccz1 are also required for
pexophagy, we induced the expression of peroxisomes by growing cells in
oleic acid in the wild type, mon1 , and ccz1
strains, and then monitored the degradation of Fox3 after cells were
shifted to glucose. Crude cell extracts were collected at the times
indicated and examined by Western blot. In wild type cells, Fox3 levels
decreased in SD-N, reflecting peroxisome degradation (Fig.
1D). In contrast, both the mon1 and
ccz1 strains maintained Fox3 at the initial level
indicating a defect in peroxisome degradation. Therefore, we conclude
that both Mon1 and Ccz1 are part of the mechanism shared by the Cvt, autophagy, and pexophagy pathways.
Ccz1 and Mon1 Are Required for Multiple Vacuole Delivery
Pathways--
It has been reported that the ccz1 strain
exhibits a severe vacuolar hydrolase sorting defect as well as a
fragmented vacuole phenotype (11). To gain a better understanding of
vacuole protein delivery in the mon1 strain, we examined
different cargo proteins that are targeted to the vacuole by various
mechanisms. Carboxypeptidase Y, Prc1, is transported to the vacuole
through the CPY pathway, a transport itinerary that includes the ER,
Golgi complex, and endosome. In the wild type strain, Prc1 is matured
(mPrc1) with a half-time of 5-10 min. Approximately 5% of Prc1 is
secreted from the cell under standard conditions used for this type of analysis (Fig. 2A). In
contrast, in typical vps mutants such as vps5,
Prc1 remains as precursor, and the majority is secreted into the
extracellular fraction as the p2 (Golgi-modified precursor) form. In
the mon1 strain, a small amount of mPrc1 (~5%) was
found in the intracellular fraction. However, the majority of the
protein was found in the p2 form even after 30 min of chase, and
approximately half was missorted to the extracellular fraction (Fig.
2A). Similar results were seen with Pep4 (data not shown).
The Prc1-processing defect in the ccz1 strain has already
been published (11). Consistent with the published data, the
ccz1 strain showed a Prc1 sorting defect by pulse/chase
analysis but accumulated a substantial amount of mPrc1 under
steady-state conditions (data not shown). The steady-state accumulation
of mPrc1 probably reflects a block in exit from a pre-vacuolar
compartment that has attained protease-processing capacity (34).

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 2.
Multiple vacuole transport pathways are
blocked in the ccz1 and
mon1 strains. A, the
mon1 strain missorts Prc1 into the extracellular
fraction. The wild type (WT, SEY6210), vps5, and
mon1 (JSY1) strains were grown to mid-log phase and
converted into spheroplasts. The spheroplasts were labeled for 5 min
and subjected to a non-radioactive chase for the time indicated at
30 °C. Samples were separated into intracellular (I) and
extracellular (E) fractions, immunoprecipitated with
antiserum to Prc1, and separated by SDS-PAGE. B,
mon1 and ccz1 strains accumulate precursor
Pho8. The wild type, pep4 (TVY1), ccz1
(CWY3), and mon1 strains were grown to mid-log phase
in SMD medium and analyzed by immunoblot using antiserum
against Pho8. C, GFP-Pho8 reaches the vacuoles of
the ccz1 and mon1 strains. Wild
type, ccz1 , mon1 , and
vam3 (CWY40) strains were transformed with pGFP-Pho8
(426) and grown in SMD medium to mid-log phase followed by fluorescence
microscopy. D, endocytic and MVB vesicles accumulated in the
ccz1 and mon1 cells outside of their
vacuoles. The wild type, ccz1 , and mon1
strains expressing the endocytosis pathway marker Ste3-GFP (316), or
the MVB pathway marker Sna3 GFP(416) were grown to mid-log phase
followed by fluorescence microscopy. DIC,
differential interference contrast.
|
|
Next, we examined the delivery of the vacuole integral membrane protein
Pho8 through the ALP pathway. Under steady-state conditions, both the
mon1 and ccz1 strains showed an ~50%
block of Pho8 processing, while the wild type strain accumulated mature
Pho8 (Fig. 2B and Ref. 11). To further examine the delivery
of Pho8 in these two mutant strains, we followed the localization of
GFP-Pho8. We used a vam3 strain as a control because the
v-SNARE Vam3 is required for the ALP pathway. Wild type,
ccz1 , mon1 , and vam3 strains
expressing GFP-Pho8 were grown to mid-log phase and examined by
fluorescent microscopy. Similar to the severe vacuole fragmentation in
the vam3 strain, both ccz1 and
mon1 also displayed a fragmented vacuole phenotype,
although a substantial population of cells exhibited some relatively
larger vacuoles (Fig. 2, C and D). In wild type
cells, GFP-Pho8 was detected at the vacuole membrane indicating proper
delivery of this hydrolase to the vacuole. In contrast to the wild type
cells, GFP-Pho8 accumulated in multiple punctate structures in the
vam3 strain (Fig. 2C). Although vacuoles in
the vam3 strain are highly fragmented, we were able to
conclude that none of these fluorescent dots were inside of the
fragmented vacuoles. We found that both the ccz1 and
mon1 strains accumulated GFP-Pho8 on the vacuole membrane
but also displayed some punctate GFP-Pho8 dots outside of their
fragmented vacuoles, suggesting only a partial block in the delivery of
Pho8 (Fig. 2C). Similar results were observed by examining
cells expressing Nyv1-GFP, which is also delivered to the vacuole by
the ALP pathway (data not shown). These data suggest a partial block in
the ALP pathway in the mon1 and ccz1 strains.
In addition to the Cvt/Apg, CPY, and ALP pathways, proteins destined
for the vacuole also transit through the endocytic and MVB pathways. We
monitored endocytosis by looking at the localization of Ste3-GFP in the
mon1 and ccz1 strains. Ste3 is the
a factor receptor and is down-regulated by both
ligand-dependent and ligand-independent modes of
endocytosis (35). In this study, we examined the ligand-independent mode. In the wild type strain, Ste3-GFP was diffusely accumulated in
the vacuole (Fig. 2D). In contrast, Ste3-GFP was localized to multiple punctate structures outside of the vacuole in the mon1 and ccz1 strains. These structures may
represent endocytic vesicles. These data indicate an endocytic defect
in the mon1 and ccz1 strains. Finally, we
examined the localization of Sna3-GFP through the MVB pathway (24). In
contrast to the vacuole lumen staining seen in the wild type cells,
Sna3-GFP in the ccz1 and mon1 cells
displayed a large population of small punctate structures outside of
vacuoles (Fig. 2D), which may represent the late
endosome/MVB compartments. Similar results were seen using other MVB
pathway marker proteins including Phm5-GFP and GFP-CPS (data not shown).
Ccz1 and Mon1 Are Required for Vesicle Fusion with the
Vacuole--
The majority of cvt, apg, and
aut mutants identified previously were specific to the Cvt
and autophagy pathways and did not show defects in other vacuole
delivery pathways. These mutants all appear to function at the stage of
vesicle induction and/or formation. However, the cvt4 and
cvt8 mutants were found to be allelic with
VPS39/VAM6 and VPS41/VAM2, respectively (25),
indicating a possible overlap with genes whose products play a more
general role in vacuole protein localization. Because the
mon1 and ccz1 mutants are defective in
multiple vacuole delivery pathways, we propose that Mon1 and Ccz1 have
general roles for protein trafficking pathways presumably through their
requirements for the vesicle fusion step with the vacuole.
To carefully examine the proposed role of Ccz1 and Mon1 for the fusion
of vesicles with the vacuole, we utilized biochemical assays that
monitor the block in the transport of prApe1 (17). To determine whether
prApe1 was able to bind membrane, we performed a flotation analysis. A
total membrane fraction from lysed spheroplasts was subjected to
centrifugation through a Ficoll step gradient. In the
mon1 strain, a portion of prApe1 and the integral ER
membrane control protein Dpm1 were pelletable and separated into the
float (F) fraction in the absence of detergent (Fig.
3A). In contrast, the
cytosolic protein Pgk1 was found exclusively in the supernatant (S)
fraction. A similar result was seen with the ccz1 strain (data not shown). This result suggests that prApe1 is able to bind to
its target membrane.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 3.
Mon1 and Ccz1 are required after
completion of Cvt vesicles. A, precursor Ape1 is
membrane associated in the mon1 strain. The
mon1 (JSY1) strain was grown to mid-log phase and
converted into spheroplasts. The spheroplasts were lysed osmotically
and centrifuged through a Ficoll step gradient with or without Triton
X-100 as described under "Experimental Procedures."
Membrane-containing float (F), non-float (NF),
and pellet (P2) fractions were collected and subjected to
immunoblot using antisera or antibodies to Ape1, Dpm1, and Pgk1.
B, precursor Ape1 is protease-protected in the
mon1 and ccz1 strains. The
apg7 (VDY101), ypt7 (WSY99),
mon1 , and ccz1 (CWY3) strains were grown to
mid-log phase and converted into spheroplasts followed by osmotic
lysis. The total lysate (T) was resolved into supernatant
(S) and pellet (P) fractions by a 13,000 × g centrifugation, and a portion analyzed by immunoblot using
antiserum to Ape1 and Pgk1. The remaining pellet fractions were
subjected to protease treatment in the absence or presence of Triton
X-100 and subjected to immunoblot using antiserum to Ape1.
C, Cvt pathway marker GFP-Aut7 accumulated outside of the
vacuole in the mon1 and ccz1 strains. The
wild type, ccz1 , and mon1 strains were
transformed with pCuGFPAut7 (22). The strains were grown to mid-log
phase, and images were taken with a fluorescent microscope.
|
|
To determine if prApe1 is sequestered within completed Cvt vesicles, we
next carried out a protease-sensitivity analysis. Spheroplasts were
osmotically lysed as described under "Experimental Procedures," and
the low speed pellet fractions were subjected to exogenous proteinase K
treatment in the absence or presence of detergent. The
apg7 strain is defective in the conjugation of Apg12 to
Apg5 and is unable to form completed Cvt vesicles/autophagosomes (36,
37). This strain accumulates prApe1 in a protease-sensitive state in
the absence of detergent (Fig. 3B). Ypt7 is a Rab protein that is required for the fusion of Cvt vesicles/autophagosomes with the
vacuole (37), and ypt7 cells accumulate
protease-protected prApe1. Precursor Ape1 in the mon1 and
ccz1 strains was also protease-protected in the absence
of detergent (Fig. 3B), suggesting that it accumulated
within completed vesicles. The separation of Pgk1 into the supernatant
fraction verifies that accumulation of protease-protected prApe1 was
not due to inefficient spheroplast lysis.
To determine whether prApe1 was present within cytosolic or subvacuolar
vesicles, we extended our analysis of the Cvt pathway by looking at
GFP-Aut7 in vivo. Aut7 is required for Cvt vesicle and
autophagosome formation and remains associated with these vesicles
following completion (22, 38). Thus, it serves as a vesicle marker.
Consistent with previously published data, GFP-Aut7 was seen as a
single punctate structure accumulating outside the vacuole in the wild
type cells grown in rich medium (Fig. 3C, SMD).
Under starvation conditions, Aut7 is induced, and we observed a bright
vacuole lumen staining of GFP-Aut7 in the wild type strain (Fig.
3C, SD-N). In contrast, GFP-Aut7 in the
mon1 and ccz1 strains displayed multiple
punctate dots similar to that seen in ypt7 cells (Fig.
3C and Ref. 39). By overlaying the fluorescent and DIC
images, we could determine that the multiple punctate structures in
these two strains were located outside of the fragmented vacuoles.
Under starvation conditions, we detected a stronger GFP-Aut7 signal in
the two mutant strains suggesting that they are not defective in Aut7
induction. Some larger double membrane structures that might represent
autophagosomes were detected outside of vacuoles in the two mutant
strains but none of the GFP-Aut7 appeared to be coincident with the
vacuole. Overall, these data suggest that prApe1 is accumulated within
completed cytosolic vesicles in both the mon1 and
ccz1 strains. Thus, we conclude that Ccz1 and Mon1 are
required for the fusion step of these vesicles with the vacuole.
Ccz1 and Mon1 Are Membrane-associated Proteins--
In order to
study the localization of Ccz1 and Mon1, we tagged both proteins with
the HA epitope. The COOH-terminal HA tagging did not cause dysfunction
of Ccz1 or Mon1, because the respective constructs on plasmids
complemented the prApe1-sorting defect of null cells and rescued the
fragmented vacuole phenotypes (data not shown). It has been shown that
Ccz1 is enriched in the P13 and P100 fractions (11). We decided to
check Mon1-HA localization together with Ccz1-HA. A strain with Mon1-HA
tagged at the chromosomal locus was transformed with pCCZ1-HA(416),
grown to mid-log phase, and converted to spheroplasts followed by
osmotic lysis. The lysed spheroplasts were subjected to velocity
sedimentation as described under "Experimental Procedures." The
cytosolic protein Pgk1 was recovered primarily from the S100 fraction,
while the vacuole membrane protein Pho8 was located exclusively in the
P13 fraction indicating efficient separation (Fig.
4A). We also examined the localization of Ypt7 and found it was mostly in the P13 fraction. Mon1-HA was recovered in the P13 and P100 fractions; however, we found
that Ccz1-HA was not only detected in the P13 and P100 fractions but
that a substantial amount also appeared in the S100 fraction indicating
a cytosolic population of this protein (Fig. 4A). Next we
extended our analyses for these two proteins by examining the stability
of their membrane binding. We found that both Ccz1-HA and Mon1-HA were
largely stripped from the membrane by treatment with 0.1 M
Na2CO3 (pH 10.5) and 3 M urea,
while approximately half of each protein remained membrane bound in the
presence of 1 M KCl and 1% Triton X-100 (Fig.
4B). Taken together, these data suggest that Ccz1-HA and
Mon1-HA are peripherally attached to a membrane compartment(s) that are
relatively detergent insoluble. The lack of solubility in the presence
of detergent may indicate that both proteins associate with a large
protein complex.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 4.
Ccz1 and Mon1 are peripheral membrane
proteins. A, Ccz1-HA and Mon1-HA are pelletable. A
strain with an HA tag at the Mon1 locus (PSY35) transformed with
pCCZ1-HA(416) was grown to mid-log phase and converted into
spheroplasts, followed by osmotic lysis in PS200 buffer containing 5 mM MgCl2. The total (T) fraction was
separated into low speed supernatant (S13) and pellet
(P13) fractions by a 13,000 × g
centrifugation step. The S13 fraction was further separated into
high-speed supernatant (S100) and pellet (P100)
fractions by centrifugation at 100,000 × g. The
collected fractions were subjected to immunoblot using antisera to HA,
Pgk1, Ypt7, and Pho8. The asterisk marks a cross-reacting
band that migrates below Pho8. B, biochemical
characterization of pelletable Ccz1-HA and Mon1-HA. Spheroplasts from
the Mon1-HA and Ccz1-HA (PSY36) strains were osmotically lysed and spun
as described under "Experimental Procedures." The pellet fractions
were resuspended in buffer alone or buffer containing 1 M
KCl, 0.1 M Na2CO3, pH 10.5, 3 M urea, or 1% Triton X-100 and separated into supernatant
(S) and pellet (P) fractions. Samples were
resolved by immunoblot with anti-HA antiserum.
|
|
In Vivo Localization of Ccz1-GFP and GFP-Mon1--
To investigate
the site of action of Ccz1 and Mon1 in vivo, we constructed
strains where GFP was fused to the COOH terminus of the MON1
and CCZ1 ORFs at the chromosomal loci. These strains displayed a normal vacuolar phenotype indicating that the expressed fusion proteins are functional (Fig. 5).
When cells grown in YPD to mid-log phase (and washed in minimal medium)
were examined, Ccz1-GFP was detected in 2-5 perivacuolar dots per cell
and also displayed a faint vacuole membrane staining (Fig.
5A). These GFP-staining dot structures were very mobile and
could be seen to move around the vacuoles (data not shown). Mon1-GFP
had a similar staining pattern to Ccz1-GFP, although the fluorescent
signal was weaker.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 5.
In vivo localization of Ccz1 and
Mon1. Yeast strains with Ccz1-GFP (PSY46) and Mon1-GFP (PSY47)
integrated at the chromosomal loci were grown to mid-log phase in YPD,
then washed and resuspended in SMD medium (A) or
H2O (B) before being examined by fluorescence microscopy.
Ccz1 and Mon1 localize to punctate perivacuolar structures and osmotic
shock results in a redistribution to the vacuolar rim. DIC,
differential interference contrast. C, a yeast strain with
chromosomal Ccz1-GFP (PSY46) was grown in YPD to mid-log phase, washed,
and resuspended in water for 5 min, followed by a shift to SMD
conditions prior to fluorescence microscopy. Images were taken at
minute intervals after the SMD treatment as indicated. Ccz1-GFP
gradually redistributed to the punctate structures within 5 min based
on time-lapse microscopy. The vacuolar rim staining is difficult to
detect due to photobleaching resulting from the time-lapse exposures.
Essentially identical results were obtained for Mon1-GFP.
|
|
Washing yeast cells under low osmotic conditions causes multilobed
vacuoles to fuse together and swell. When the Ccz1-GFP and Mon1-GFP
yeast were washed with water prior to microscopy, the vacuoles could be
seen to enlarge (Fig. 5B). The punctate staining pattern of
Ccz1-GFP and Mon1-GFP was largely lost and was replaced by an increased
signal on the vacuolar rim. Furthermore, by shifting the hypotonic
treatment back to SMD, we were able to recover the punctate-staining
pattern along with the fainter vacuole ring localization of Ccz1-GFP
and Mon1-GFP (Fig. 5C). The punctate pattern appeared
rapidly and became saturated within 5 min of reversing the osmotic
conditions. Therefore, we conclude that the majority of Ccz1-Mon1
complexes localize to several membrane structures right next to the
vacuole and could possibly attach to the vacuole membrane to achieve
their function.
Because both proteins displayed a similar subcellular distribution by
fluorescent microscopy, we extended the analysis by examining the
co-localization of YFP- and CFP-tagged proteins. Because Mon1 tagged
chromosomally at the COOH terminus with CFP or YFP showed a very weak
fluorescent signal, we replaced chromosomal MON1 with
YFP-MON1 under the control of the CUP1 promoter.
The resulting strain showed normal vacuolar morphology (Fig.
6A). Ccz1-CFP and YFP-Mon1
showed multiple punctate dots similar to the pattern seen with the
GFP-tagged constructs. Furthermore, the two proteins co-localized (Fig.
6A). The staining pattern seen with GFP-Mon1 and Ccz1-GFP
was different from the single punctate structure observed with most
Apg/Cvt proteins that localize to the pre-autophagosomal structure
(20). To determine whether Mon1 and Ccz1 localized to a distinct
compartment, we compared the distribution of Ccz1-YFP to Cvt19-CFP.
Cvt19 is a receptor or adaptor for prApe1 (40) and localizes to the
pre-autophagosomal structure (20). We found that the punctate dots
corresponding to Ccz1-YFP did not co-localize with the
pre-autophagosomal structure represented by Cvt19-CFP (Fig.
6B).

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 6.
Ccz1 and Mon1 co-localize to a perivacuolar
compartment different from the pre-autophagosomal structure.
A, strain PSY45 expressing YFP-Mon1 from the CUP1
promoter and Ccz1-CFP was grown to mid-log phase in YPD. YFP-Mon1
expression was induced with 50 µM CuSO4 for
1 h prior to microscopy. B, strain PSY42 expressing
Ccz1-YFP from the chromosomal loci and Cvt19-CFP from a plasmid, was
grown to mid-log phase in SMD and then for 1 h in YPD. All cells
were washed once in SMD before being examined by fluorescence
microscopy.
|
|
Ccz1 and Mon1 Form a Stable Protein Complex--
We have shown
that the ccz1 and mon1 strains have similar
vacuole protein transport defects, and that Ccz1 and Mon1 are both
pelletable and that their association with membranes has similar
biochemical properties. In addition, both proteins co-localized by
fluorescent microscopy (Fig. 6A). To further investigate the subcellular localization of Ccz1-HA and Mon1-HA, we resolved the membrane compartments on an OptiPrep density gradient as described under "Experimental Procedures." After centrifugation, fractions were collected from the top of the gradient and analyzed by immunoblot. Ccz1-HA and Mon1-HA were both detected in fractions 8 through 13 (Fig.
7A). We compared their
distribution with endomembrane markers Dpm1 (ER), Anp1 (Golgi), Pep12
(endosome), and Pho8 (vacuole). All these proteins displayed
fractionation patterns that were distinct from Ccz1-HA and Mon1-HA. We
also checked the localization of Ypt7 that has been suggested to
interact with Ccz1, and found that a population of these proteins
overlapped in fractions 8 and 9, but that the peaks were distinct (Fig.
7A).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 7.
Ccz1 and Mon1 physically interact.
A, Ccz1 and Mon1 co-fractionated but were separated from
endomembrane marker proteins by OptiPrep density gradients. The Mon1-HA
strain (PSY35) expressing pCCZ1-HA(416) was analyzed by density
gradient separation as described under "Experimental Procedures."
Fractions were subjected to immunoblot using antisera or antibodies to
Dpm1 (ER), Anp1 (Golgi), Pep12 (endosome), Pho8 (vacuole), Ypt7, and
HA. B, Ccz1-HA co-precipitates Mon1 by native
immunoprecipitation. Wild type, ccz1 (CWY3), and
mon1 (JSY1) strains were transformed with pCCZ1-HA(426),
pMON1(426), and/or pYPT7(424), and were grown to mid-log phase followed
by glass bead lysis in HEPES native immunoprecipitation buffer. An
aliquot (10 µl) of lysate was used as the loading control. Lysates
were incubated with anti-HA antibody and protein A-Sepharose as
described under "Experimental Procedures" and subjected to
immunoblot against HA, Mon1, and Ypt7.
|
|
To extend this analysis we examined whether Ccz1 physically interacts
with Mon1, using a co-immunoprecipitation assay. We expressed a
combination of pCCZ1-HA(426), pMON1 (426), and pYPT7(424) in several
strain backgrounds (Fig. 7B). Overexpression of the respective proteins did not cause any significant effect for the wild
type or mutant strains with regard to prApe1 maturation (data not
shown). Cells were lysed with glass beads, and the crude cell lysate
was subjected to Western blot as the loading control (Fig. 7B, input). We generated polyclonal antiserum
against Mon1 as described under "Experimental Procedures." The
antiserum detected a very weak band of ~70 kDa in the wild type
strain and showed a greatly increased level of this band in cells
expressing a multicopy MON1 plasmid (Fig. 7B and
data not shown). Cells were subjected to a native immunoprecipitation
with antiserum against HA as described under "Experimental
Procedures." The precipitated immune complexes (affinity isolate)
were then subjected to SDS-PAGE and Western blots using antibodies or
antiserum against HA, Mon1, and Ypt7. In the wild type strain
containing overexpressed Ccz1-HA, the immune complex pulled down a
substantial amount of the chromosomal Mon1 (Fig. 7B). The
immunoaffinity signal is specific against Mon1 because no Mon1 signal
was detected in the mon1 strain under the same
immunoprecipitation conditions. When Mon1 was overexpressed in the
absence of Ccz1-HA, none of the Mon1 could be detected in the immune
complex indicating that the isolation of Mon1 was dependent on Ccz1
(Fig. 7B). The reverse interaction was also observed when we
carried out the immunoprecipitation using antiserum against Mon1 (data
not shown). It has been published previously that Ccz1-HA
co-immunoprecipitates with Ypt7 (12). However, we were unable to detect
any Ypt7 signal in this experiment. It is possible that the interaction
between Ypt7 and Ccz1 (and maybe also Mon1) is transient, whereas the
interaction between Ccz1 and Mon1 is abundant and stable.
 |
DISCUSSION |
Ccz1 and Mon1 Are Required in Multiple Pathways to the Yeast
Vacuole--
The biosynthetic Cvt pathway that delivers the precursor
form of the vacuolar hydrolase Ape1 from the cytoplasm to the yeast vacuole is the subject of our investigation. We have identified many
cvt mutants and found that most of them exhibited an
extensive genetic, biochemical, and morphological overlap with
apg and aut mutants that are defective in the
degradative autophagy pathway (reviewed in Refs. 5 and 28). To gain a
comprehensive understanding of the Cvt pathway, we further identified
mutants defective in prApe1 sorting by screening the yeast deletion
library. Using this strategy, we have identified two new proteins, Ccz1
and Mon1, required for the Cvt, autophagy and pexophagy pathways (Fig.
1). To further understand the precise role(s) of these two proteins we
first performed an extensive analysis to determine whether the
ccz1 and mon1 strains had pleiotropic
effects in other vacuole transport pathways. The CPY pathway involves
transport through a portion of the secretory pathway, and its itinerary
includes the prevacuolar compartment (PVC)/endosome. We found that the CPY pathway cargo protein Prc1 was missorted as the p2 form in the
mon1 strain. A similar secretion phenotype has been shown previously for the ccz1 strain (11).
The ALP pathway diverges from the CPY pathway in the late Golgi; cargo
proteins such as Pho8 do not pass through the PVC before reaching the
vacuole. We showed a partial defect in Pho8 processing in these two
mutant strains (Fig. 2B). When we further studied the
localization of GFP-Pho8, we observed an appearance of the chimera on
fragmented vacuoles in these two mutants. In contrast, a
vam3 strain accumulated a large population of small
vesicles containing GFP-Pho8 that were not observed on the fragmented
vacuoles. Although we do see some GFP-Pho8 on intermediate vesicle
structures in the ccz1 and mon1 strains,
the majority of GFP-Pho8 targeted to their fragmented vacuoles (Fig.
2C). Thus, it appears that the ALP pathway that bypasses the
endosome is relatively unaffected in the ccz1 and
mon1 strains. The partial Pho8 processing defect might
reflect reduced processing capacity of the vacuole resulting from the
missorting of Prc1, Pep4, and other hydrolases that utilize the CPY
pathway. This possibility is supported by the observation of 50%
precursor Pho8 in purified vacuoles from the ccz1 and mon1 strains (data not shown). Analysis of Ste3-GFP and
Sna3-GFP revealed blocks in the endocytosis and MVB pathways (Fig.
2D). These data indicate that mon1 and
ccz1 have pleiotropic defects in multiple vacuole-sorting pathways.
Ccz1 and Mon1 Function at the Vesicle Fusion Step--
The
defect in multiple vacuole delivery pathways and the observation of
vesicle-like transport intermediates accumulated in the two mutants
suggested that Mon1 and Ccz1 might act at the stage of fusion with the
vacuole. Taking advantage of the established model for the Cvt/Apg
pathway (28), we could assess the role of Mon1 and Ccz1 through
biochemical analyses that examined the state of prApe1 (17). In the
past few years, we have dissected the Cvt/Apg pathway into several
discrete steps. These include vesicle nucleation and cargo
sequestration, vesicle formation/completion, docking/fusion, and
subvacuolar vesicle lysis followed by maturation of prApe1 (Fig.
8). Accordingly, we have developed
biochemical tools to assess the stage at which the cargo protein prApe1
accumulates during transport in mutant strains. The membrane flotation
analysis indicated that prApe1 in the mon1 strain was
membrane-associated (Fig. 3A). Furthermore, we found that
prApe1 in the mon1 and ccz1 strains was in
a protease-protected form, suggesting that the sequestration step for
the Cvt complex was completed. Thus, mon1 and
ccz1 are the first two mutants that have been isolated in
several screens for apg, aut, and cvt
mutants that act after completion of the sequestering vesicles.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 8.
Working model for the Cvt and autophagy
pathways. The type of vesicles that are produced depends on the
nutrient conditions. Autophagosomes form during autophagy under
conditions of nutrient deprivation. Cvt vesicles are generated through
the Cvt pathway under nutrient rich conditions. Four general steps of
both pathways are indicated below the illustration.
Components that are required for the Cvt and Apg pathways are indicated
based on their putative roles.
|
|
Protease-protected prApe1 could accumulate in subvacuolar vesicles
within the vacuole lumen in strains defective in the vesicle lysis
step. To verify that the ccz1 and mon1
strains are defective in delivery to the vacuole, we investigated the
distribution of GFP-Aut7 in the two mutant strains. Aut7 is a component
that is required for Cvt vesicle formation and is itself localized to Cvt vesicles (41). Accordingly, Aut7 serves as a useful vesicle marker.
In contrast to the single perivacuolar (SMD) or luminal (SD-N) dot
observed in the wild type strain, GFP-Aut7 is localized outside of the
vacuole in multiple punctate structures in the ccz1 and
mon1 strains (Fig. 3C). Furthermore, the
localization of GFP-Aut7 in the two mutants was very similar to that
seen in the ypt7 strain. Ypt7 is a Rab GTPase that is
required for the fusion of multiple vesicle types, including Cvt
vesicles and autophagosomes, with the vacuole (37). Taken together, our
data indicate that Ccz1 and Mon1 function at the stage of fusion of
autophagosomes/Cvt vesicles with the vacuole.
Molecular Function of Ccz1 and Mon1 in Fusion--
Ccz1 and Mon1
are both peripheral membrane proteins (Fig. 4). There is an additional
cytosolic pool of Ccz1 (Fig. 4A). The two proteins
co-localized to a relatively higher density compartment that did not
peak at the same position as most endomembrane markers (Fig.
7A). Both proteins appeared to function as a stable protein complex (Fig. 7B) termed the Ccz1-Mon1 complex in this
study. Similarly, in vivo examination of Ccz1 and Mon1
tagged with fluorescent markers suggested that the Ccz1-Mon1 complex
localizes to perivacuolar dot structures that overlap (Fig. 6). The
previously published immunofluorescent data suggest that Ccz1
co-localizes with the endosomal marker Nhx1 (11), suggesting that these
dots might represent some kind of endosome/PVC structure. Neither
protein localized to the pre-autophagosomal structure that is thought to be the site of Cvt vesicle/autophagosome synthesis or the site of
the donor membrane (Fig. 6). We have also observed faint vacuole membrane staining for both Mon1 and Ccz1, indicating these proteins might target to the vacuole membrane to achieve their function in
fusion. Although we did not observe a vacuole peak of Ccz1 and/or Mon1
in our OptiPrep density gradient, we could not rule out the possibility
that their association with the vacuole is relatively weak and is lost
during the biochemical procedures. A similar phenotype is seen with
Cvt18, which is lost from the vacuole following spheroplast lysis
(42).
A summary of the published data of the components involved in the
Cvt/Apg pathways is shown in Fig. 8. At the fusion step, SNARE proteins
including Vam3 (43), Vti1 (44), and Vam7 (45) are required for both Cvt
vesicle and autophagosome fusion with the vacuole. Ypt7, the Rab GTPase
(37), and its proposed effector complex, termed the class C Vps/HOPS
(homotypic fusion and vacuole protein sorting) complex that comprises
Vps11, Vps16, Vps18, Vps33, Vps39, and Vps41 (25, 46), is also
essential machinery at this step. Among these identified components
required for the Cvt vesicle/autophagosome fusion step, none retain a
normal vacuole phenotype when they are deleted from the genome. On the
other hand, most but not all mutants that exhibit a vacuole
fragmentation phenotype are defective for the Cvt/autophagy pathway.
For example, although the kcs1 strain showed a fragmented
vacuole phenotype, it accumulated the mature form of Ape1 (Ref.
47).2 Similarly, some
vps mutants such as vps5 have fragmented vacuoles but are essentially normal for import of prApe1 (15). In this study we
introduce the novel Ccz1-Mon1 complex as acting at the fusion step in
the Apg/Cvt pathways, as well as in most other pathways that involve
vesicle fusion with the vacuole. Because of its apparently general role
in vacuole biogenesis and function, it is important to examine whether
the Ccz1-Mon1 complex is part of the basic vacuole fusion mechanism.
For example, what is the specific molecular role of the Ccz1-Mon1
complex? Ccz1 has been reported to interact with Ypt7 (12). Is the
Ccz1-Mon1 complex also part of the Ypt7 effector complex? Although our
co-immunoprecipitation data did not reproduce the published result of
Ccz1-HA and Ypt7 interaction, we suggest that this interaction is
transient whereas the Ccz1-Mon1 complex is very abundant and stable. We
are currently trying to determine the specific role of the Ccz1-Mon1
complex in the Cvt and Apg pathways. An in vitro analysis
will provide additional insight into their function in the mechanism of
vesicle fusion.
 |
ACKNOWLEDGEMENTS |
We thank Drs. Scott Emr, Mark Longtine, Sean
Munro, Jeremy Thorner, and William Wickner and the Yeast Resource
Center for supplying antiserum and plasmids. We thank members of the
Klionsky laboratory, especially Drs. Fulvio Reggiori and John Kim, for helpful discussions and providing plasmids.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Public Health Service Grant GM53396 (to D. J. K.), the Lewis E. and Elaine Prince Wehmeyer Trust (to C.-W. W.), and a research fellowship from the Science and Technology Agency of Japan (to J. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Yeast Laboratory, National Food Research
Institute, Tsukuba, Ibaraki 305-8642, Japan.
¶
To whom correspondence should be addressed: University of
Michigan, Dept. of Molecular, Cellular and Developmental Biology, Ann Arbor, MI 48109-1048. Tel.: 734-615-6556; Fax: 734-647-0884; E-mail: klionsky@umich.edu.
Published, JBC Papers in Press, October 2, 2002, DOI 10.1074/jbc.M208191200
2
P. E. Stromhaug and D. J. Klionsky,
unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
CPY, carboxypeptidase Y;
ALP, alkaline phosphatase;
Ape1, aminopeptidase I;
CFP, cyan fluorescent protein;
Cvt, cytoplasm to vacuole targeting;
GFP, green fluorescent protein;
prApe1, precursor aminopeptidase I;
PVC, pre-vacuolar compartment;
SMD, synthetic minimal medium with
dextrose;
SD/-N, synthetic minimal medium with dextrose but lacking
nitrogen;
YFP, yellow fluorescent protein;
ORF, open reading frame;
MES, 4-morpholineethanesulfonic acid;
PIPES, 1,4-piperazinediethanesulfonic acid.
 |
REFERENCES |
| 1.
|
Klionsky, D. J.,
Herman, P. K.,
and Emr, S. D.
(1990)
Microbiol. Rev.
54,
266-292[Abstract/Free Full Text]
|
| 2.
|
Kim, J.,
Scott, S. V.,
and Klionsky, D. J.
(2000)
Int. Rev. Cytol.
198,
153-201[Medline]
[Order article via Infotrieve]
|
| 3.
|
Lemmon, S. K.,
and Traub, L. M.
(2000)
Curr. Opin. Cell Biol.
12,
457-466[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Weisman, L. S.,
and Wickner, W.
(1988)
Science
241,
589-591[Abstract/Free Full Text]
|
| 5.
|
Klionsky, D. J.,
and Ohsumi, Y.
(1999)
Annu. Rev. Cell Dev. Biol.
15,
1-32[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Klionsky, D. J.
(1998)
J. Biol. Chem.
273,
10807-10810[Free Full Text]
|
| 7.
|
Baba, M.,
Osumi, M.,
Scott, S. V.,
Klionsky, D. J.,
and Ohsumi, Y.
(1997)
J. Cell Biol.
139,
1687-1695[Abstract/Free Full Text]
|
| 8.
|
Scott, S. V.,
Baba, M.,
Ohsumi, Y.,
and Klionsky, D. J.
(1997)
J. Cell Biol.
138,
37-44[Abstract/Free Full Text]
|
| 9.
|
Klionsky, D. J.,
and Emr, S. D.
(2000)
Science
290,
1717-1721[Abstract/Free Full Text]
|
| 10.
|
Harding, T. M.,
Hefner-Gravink, A.,
Thumm, M.,
and Klionsky, D. J.
(1996)
J. Biol. Chem.
271,
17621-17624[Abstract/Free Full Text]
|
| 11.
|
Kucharczyk, R.,
Dupre, S.,
Avaro, S.,
Haguenauer-Tsapis, R.,
Slonimski, P. P.,
and Rytka, J.
(2000)
J. Cell Sci.
113,
4301-4311[Abstract]
|
| 12.
|
Kucharczyk, R.,
Kierzek, A. M.,
Slonimski, P. P.,
and Rytka, J.
(2001)
J. Cell Sci.
114,
3137-3145[Abstract/Free Full Text]
|
| 13.
|
Muren, E.,
Oyen, M.,
Barmark, G.,
and Ronne, H.
(2001)
Yeast
18,
163-172[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Bahler, J., Wu, J. Q.,
Longtine, M. S.,
Shah, N. G.,
McKenzie, A., III,
Steever, A. B.,
Wach, A.,
Philippsen, P.,
and Pringle, J. R.
(1998)
Yeast
14,
943-951[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Klionsky, D. J.,
Cueva, R.,
and Yaver, D. S.
(1992)
J. Cell Biol.
119,
287-299[Abstract/Free Full Text]
|
| 16.
|
Klionsky, D. J.,
Banta, L. M.,
and Emr, S. D.
(1988)
Mol. Cell. Biol.
8,
2105-2116[Abstract/Free Full Text]
|
| 17.
|
Wang, C.-W.,
Kim, J.,
Huang, W.-P.,
Abeliovich, H.,
Stromhaug, P. E.,
Dunn, W. A., Jr.,
and Klionsky, D. J.
(2001)
J. Biol. Chem.
276,
30442-30451[Abstract/Free Full Text]
|
| 18.
|
Noda, T.,
Kim, J.,
Huang, W.-P.,
Baba, M.,
Tokunaga, C.,
Ohsumi, Y.,
and Klionsky, D. J.
(2000)
J. Cell Biol.
148,
465-480[Abstract/Free Full Text]
|
| 19.
|
Rehling, P.,
Darsow, T.,
Katzmann, D. J.,
and Emr, S. D.
(1999)
Nat. Cell Biol.
1,
346-353[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Kim, J.,
Huang, W.-P.,
Stromhaug, P. E.,
and Klionsky, D. J.
(2002)
J. Biol. Chem.
277,
763-773[Abstract/Free Full Text]
|
| 21.
|
Urbanowski, J. L.,
and Piper, R. C.
(1999)
J. Biol. Chem.
274,
38061-38070[Abstract/Free Full Text]
|
| 22.
|
Kim, J.,
Huang, W.-P.,
and Klionsky, D. J.
(2001)
J. Cell Biol.
152,
51-64[Abstract/Free Full Text]
|
| 23.
|
Cowles, C. R.,
Snyder, W. B.,
Burd, C. G.,
and Emr, S. D.
(1997)
EMBO J.
16,
2769-2782[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Reggiori, F.,
and Pelham, H. R. B.
(2001)
EMBO J.
20,
5176-5186[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Harding, T. M.,
Morano, K. A.,
Scott, S. V.,
and Klionsky, D. J.
(1995)
J. Cell Biol.
131,
591-602[Abstract/Free Full Text]
|
| 26.
|
Kim, J.,
Kamada, Y.,
Stromhaug, P. E.,
Guan, J.,
Hefner-Gravink, A.,
Baba, M.,
Scott, S. V.,
Ohsumi, Y.,
Dunn, W. A., Jr.,
and Klionsky, D. J.
(2001)
J. Cell Biol.
153,
381-396[Abstract/Free Full Text]
|
| 27.
|
Vida, T. A.,
and Emr, S. D.
(1995)
J. Cell Biol.
128,
779-792[Abstract/Free Full Text]
|
| 28.
|
Kim, J.,
and Klionsky, D. J.
(2000)
Annu. Rev. Biochem.
69,
303-342[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Kucharczyk, R.,
Gromadka, R.,
Migdalski, A.,
Slonimski, P. P.,
and Rytka, J.
(1999)
Yeast
15,
987-1000[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Abeliovich, H.,
Dunn, W. A., Jr.,
Kim, J.,
and Klionsky, D. J.
(2000)
J. Cell Biol.
151,
1025-1034[Abstract/Free Full Text]
|
| 31.
|
Scott, S. V.,
Nice, D. C., III,
Nau, J. J.,
Weisman, L. S.,
Kamada, Y.,
Keizer-Gunnink, I.,
Funakoshi, T.,
Veenhuis, M.,
Ohsumi, Y.,
and Klionsky, D. J.
(2000)
J. Biol. Chem.
275,
25840-25849[Abstract/Free Full Text]
|
| 32.
|
Kamada, Y.,
Funakoshi, T.,
Shintani, T.,
Nagano, K.,
Ohsumi, M.,
and Ohsumi, Y.
(2000)
J. Cell Biol.
150,
1507-1513[Abstract/Free Full Text]
|
| 33.
|
Hutchins, M. U.,
Veenhuis, M.,
and Klionsky, D. J.
(1999)
J. Cell Sci.
112,
4079-4087[Abstract]
|
| 34.
|
Piper, R. C.,
Cooper, A. A.,
Yang, H.,
and Stevens, T. H.
(1995)
J. Cell Biol.
131,
603-617[Abstract/Free Full Text]
|
| 35.
|
Chen, L.,
and Davis, N. G.
(2000)
J. Cell Biol.
151,
731-738[Abstract/Free Full Text]
|
| 36.
|
Tanida, I.,
Mizushima, N.,
Kiyooka, M.,
Ohsumi, M.,
Ueno, T.,
Ohsumi, Y.,
and Kominami, E.
(1999)
Mol. Biol. Cell
10,
1367-1379[Abstract/Free Full Text]
|
| 37.
|
Kim, J.,
Dalton, V. M.,
Eggerton, K. P.,
Scott, S. V.,
and Klionsky, D. J.
(1999)
Mol. Biol. Cell
10,
1337-1351[Abstract/Free Full Text]
|
| 38.
|
Kirisako, T.,
Ichimura, Y.,
Okada, H.,
Kabeya, Y.,
Mizushima, N.,
Yoshimori, T.,
Ohsumi, M.,
Takao, T.,
Noda, T.,
and Ohsumi, Y.
(2000)
J. Cell Biol.
151,
263-276[Abstract/Free Full Text]
|
| 39.
|
Suzuki, K.,
Kirisako, T.,
Kamada, Y.,
Mizushima, N.,
Noda, T.,
and Ohsumi, Y.
(2001)
EMBO J.
20,
5971-5981[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Scott, S. V.,
Guan, J.,
Hutchins, M. U.,
Kim, J.,
and Klionsky, D. J.
(2001)
Mol. Cell
7,
1131-1141[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Huang, W.-P.,
Scott, S. V.,
Kim, J.,
and Klionsky, D. J.
(2000)
J. Biol. Chem.
275,
5845-5851[Abstract/Free Full Text]
|
| 42.
|
Guan, J.,
Stromhaug, P. E.,
George, M. D.,
Habibzadegah-Tari, P.,
Bevan, A.,
Dunn, W. A., Jr.,
and Klionsky, D. J.
(2001)
Mol. Biol. Cell
12,
3821-3838[Abstract/Free Full Text]
|
| 43.
|
Darsow, T.,
Rieder, S. E.,
and Emr, S. D.
(1997)
J. Cell Biol.
138,
517-529[Abstract/Free Full Text]
|
| 44.
|
Fischer von Mollard, G.,
and Stevens, T. H.
(1999)
Mol. Biol. Cell
10,
1719-1732[Abstract/Free Full Text]
|
| 45.
|
Sato, T. K.,
Darsow, T.,
and Emr, S. D.
(1998)
Mol. Cell. Biol.
18,
5308-5319[Abstract/Free Full Text]
|
| 46.
|
Sato, T. K.,
Rehling, P.,
Peterson, M. R.,
and Emr, S. D.
(2000)
Mol. Cell
6,
661-671[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Seeley, E. S.,
Kato, M.,
Margolis, N.,
Wickner, W.,
and Eitzen, G.
(2002)
Mol. Biol. Cell
13,
782-794[Abstract/Free Full Text]
|
| 48.
|
Robinson, J. S.,
Klionsky, D. J.,
Banta, L. M.,
and Emr, S. D.
(1988)
Mol. Cell. Biol.
8,
4936-4948[Abstract/Free Full Text]
|
| 49.
|
Wurmser, A. E.,
and Emr, S. D.
(1998)
EMBO J.
17,
4930-4942[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Gerhardt, B.,
Kordas, T. J.,
Thompson, C. M.,
Patel, P.,
and Vida, T.
(1998)
J. Biol. Chem.
273,
15818-15829[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Pokrzywa, B. Guerriat, J. Dodzian, and P. Morsomme
Dual Sorting of the Saccharomyces cerevisiae Vacuolar Protein Sna4p
Eukaryot. Cell,
March 1, 2009;
8(3):
278 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Flower, C. Clark-Dixon, C. Metoyer, H. Yang, R. Shi, Z. Zhang, and S. N. Witt
YGR198w (YPP1) targets A30P {alpha}-synuclein to the vacuole for degradation
J. Cell Biol.,
July 30, 2007;
177(6):
1091 - 1104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, E. Vachon, J. Zhang, V. Cherepanov, J. Kruger, J. Li, K. Saito, P. Shannon, N. Bottini, H. Huynh, et al.
Tyrosine phosphatase MEG2 modulates murine development and platelet and lymphocyte activation through secretory vesicle function
J. Exp. Med.,
December 5, 2005;
202(11):
1587 - 1597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Klionsky
The molecular machinery of autophagy: unanswered questions
J. Cell Sci.,
January 1, 2005;
118(1):
7 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Kunz, H. Schwarz, and A. Mayer
Determination of Four Sequential Stages during Microautophagy in Vitro
J. Biol. Chem.,
March 12, 2004;
279(11):
9987 - 9996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-W. Wang, P. E. Stromhaug, E. J. Kauffman, L. S. Weisman, and D. J. Klionsky
Yeast homotypic vacuole fusion requires the Ccz1-Mon1 complex during the tethering/docking stage
J. Cell Biol.,
December 8, 2003;
163(5):
973 - 985.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Reggiori, C.-W. Wang, P. E. Stromhaug, T. Shintani, and D. J. Klionsky
Vps51 Is Part of the Yeast Vps Fifty-three Tethering Complex Essential for Retrograde Traffic from the Early Endosome and Cvt Vesicle Completion
J. Biol. Chem.,
February 7, 2003;
278(7):
5009 - 5020.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|